Arriving in the landscape of excess body fat management, retatrutide is a unique approach. Different from many available medications, retatrutide works as a double agonist, simultaneously engaging both GLP peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) binding sites. The dual engagement fosters various beneficial effects,